抗原刺激在皮肤T细胞淋巴瘤中的作用
Megan E Gumina1, Madeline J Hooper2, Xiaolong A Zhou2
1Department of Pathology, Grossman School of Medicine, New York University, New York, New York, USA.
The Journal of investigative dermatology
|December 27, 2023
概括
皮肤T细胞淋巴瘤 (CTCL) 可能是由长期暴露于未知的环境因素,如化学物质或微生物引发的. 本综述探讨了将这些刺激与CTCL发展和延续联系在一起的证据.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 皮肤T细胞淋巴瘤 (CTCL) 的特点是皮肤中恶性T细胞的增殖.
- 慢性抗原刺激是CTCL的假设原因或延续因素.
- 抗原触发物,包括化学物质和微生物,被认为可以通过TCR信号来激活恶性T细胞.
研究的目的:
- 审查当前证据,支持化学和微生物刺激作为CTCL的抗原触发器.
- 总结研究CTCL中未知的抗原暴露的新兴研究领域.
主要方法:
- 对CTCL现有研究的文献综述.
- 对化学和微生物触发因素的证据分析.
- 识别未知抗原性的新研究途径.
主要成果:
- 有证据表明,某些化学和微生物暴露可能作为CTCL的抗原触发剂.
- 许多抗原触发物的特异性仍未确定.
- 需要进一步研究与暴露相关的新型抗原性.
结论:
- 化学和微生物暴露是CTCL的可信的抗原触发因素.
- 识别这些触发因素对于理解CTCL病原体至关重要.
- 未来的研究应该集中于阐明目前未知的抗原暴露在CTCL中的作用.
相关概念视频
T Cell Activation and Clonal Selection
740
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
740
Antigens Involved in Adaptive Immunity
498
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
498
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Cell-mediated Immune Responses
68.3K
Overview
68.3K
Antigen Presenting Cells
1.8K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
1.8K
Antigen Processing Pathways
1.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.0K


